Ono Pharmaceutical Co Ltd

Ono Pharmaceutical outlines a structured governance framework for its environmental and climate-related lobbying through industry associations, explaining that it evaluates its participation by "considering consistency with our business objectives, focus areas, and business activities, and regularly conduct[ing] careful examinations on whether there are no major contradictions between industry associations and our company's approach to environmental conservation." It further clarifies that "Membership in and withdrawal from initiatives and other groups, as well as policy recommendations made through initiatives, are discussed by the Environmental Committee to determine whether they are in line with our policies, and are then overseen by the Board of Directors." This demonstrates a clear policy, monitoring process, and formal oversight bodies for its indirect lobbying activities, including attendance at "discussions for policy recommendations in the RE100." However, we found no evidence of a formal mechanism for reviewing or managing direct lobbying efforts beyond these association engagements.